Squarepoint Ops LLC Sage Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

$99.2 Billion
Q4 2024

A detailed history of Squarepoint Ops LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 23,134 shares of SAGE stock, worth $166,333. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,134

Previous 141,936 83.7%

Holding current value

$166,333

Previous $1.02 Million 87.78%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$4.78 - $8.57 $567,873 - $1.02 Million	-118,802 Reduced 83.7%	23,134 $125,000
Q3 2024 Nov 14, 2024	SELL	$7.02 - $13.08 $1.2 Million - $2.24 Million	-171,471 Reduced 54.71%	141,936 $1.02 Million
Q2 2024 Aug 14, 2024	BUY	$10.58 - $17.9 $2.84 Million - $4.81 Million	268,549 Added 598.66%	313,407 $3.4 Million
Q1 2024 May 15, 2024	BUY	$18.62 - $26.95 $835,255 - $1.21 Million	44,858 New	44,858 $840,000
Q2 2023 Aug 14, 2023	SELL	$40.65 - $59.54 $969,502 - $1.42 Million	-23,850 Reduced 30.13%	55,314 $2.6 Million
Q1 2023 May 15, 2023	SELL	$37.27 - $46.57 $958,099 - $1.2 Million	-25,707 Reduced 24.51%	79,164 $3.32 Million
Q4 2022 Feb 14, 2023	SELL	$32.2 - $43.61 $943,846 - $1.28 Million	-29,312 Reduced 21.84%	104,871 $4 Million
Q3 2022 Nov 14, 2022	BUY	$32.28 - $43.27 $899,256 - $1.21 Million	27,858 Added 26.2%	134,183 $5.26 Million
Q2 2022 Aug 15, 2022	BUY	$27.52 - $37.99 $577,479 - $797,182	20,984 Added 24.59%	106,325 $3.43 Million
Q1 2022 May 16, 2022	BUY	$30.71 - $45.71 $371,161 - $552,451	12,086 Added 16.5%	85,341 $2.83 Million
Q4 2021 Feb 14, 2022	BUY	$37.06 - $47.11 $2.71 Million - $3.45 Million	73,255 New	73,255 $3.12 Million
Q3 2021 Nov 15, 2021	SELL	$40.26 - $57.37 $1.01 Million - $1.44 Million	-25,061 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$54.88 - $79.29 $1.38 Million - $1.99 Million	25,061 New	25,061 $1.42 Million
Q1 2021 May 17, 2021	SELL	$70.65 - $96.76 $729,461 - $999,047	-10,325 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$58.41 - $89.06 $84,285 - $128,513	1,443 Added 16.25%	10,325 $893,000
Q3 2020 Nov 16, 2020	SELL	$41.13 - $62.45 $4.67 Million - $7.1 Million	-113,618 Reduced 92.75%	8,882 $543,000
Q2 2020 Aug 14, 2020	BUY	$25.95 - $43.15 $2.93 Million - $4.87 Million	112,779 Added 1160.16%	122,500 $5.09 Million
Q1 2020 May 15, 2020	BUY	$26.15 - $77.24 $254,204 - $750,850	9,721 New	9,721 $279,000
Q4 2019 Feb 14, 2020	SELL	$60.18 - $154.77 $580,436 - $1.49 Million	-9,645 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$140.29 - $189.96 $1.35 Million - $1.83 Million	9,645 New	9,645 $1.35 Million
Q1 2019 May 15, 2019	SELL	$89.33 - $163.65 $2.93 Million - $5.37 Million	-32,830 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$81.94 - $139.71 $510,895 - $871,091	-6,235 Reduced 15.96%	32,830 $3.15 Million
Q3 2018 Nov 14, 2018	SELL	$138.11 - $169.04 $2.97 Million - $3.64 Million	-21,508 Reduced 35.51%	39,065 $5.52 Million
Q2 2018 Aug 14, 2018	BUY	$140.36 - $175.76 $7.88 Million - $9.87 Million	56,128 Added 1262.72%	60,573 $9.48 Million
Q1 2018 May 15, 2018	BUY	$152.15 - $192.33 $676,306 - $854,906	4,445 New	4,445 $716,000
Q4 2017 Feb 14, 2018	SELL	$60.72 - $167.34 $241,787 - $666,347	-3,982 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$61.4 - $88.52 $244,494 - $352,486	3,982	3,982 $248,000

Others Institutions Holding SAGE

# of Institutions

194

Shares Held

45M

Call Options Held

304K

Put Options Held

117K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $427M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Sage Therapeutics, Inc. Transaction History